Quadrant Capital Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.16M | Buy |
|
|||||
|
2025
Q2 | $1.17M | Buy |
|
|||||
|
2025
Q1 | $773K | Buy |
|
|||||
|
2024
Q4 | $383K | Buy |
|
|||||
|
2024
Q3 | $332K | Sell |
|
|||||
|
2024
Q2 | $533K | Buy |
|
|||||
|
2024
Q1 | $510K | Buy |
|
|||||
|
2023
Q4 | $387K | Sell |
|
|||||
|
2023
Q3 | $397K | Sell |
|
|||||
|
2023
Q2 | $690K | Sell |
|
|||||
|
2023
Q1 | $606K | Buy |
|
|||||
|
2022
Q4 | $418K | Sell |
|
|||||
|
2022
Q3 | $512K | Buy |
|
|||||
|
2022
Q2 | $554K | Buy |
|
|||||
|
2022
Q1 | $662K | Buy |
|
|||||
|
2021
Q4 | $692K | Buy |
|
|||||
|
2021
Q3 | $597K | Buy |
|
|||||
|
2021
Q2 | $526K | Buy |
|
|||||
|
2021
Q1 | $401K | Buy |
|
|||||
|
2020
Q4 | $405K | Sell |
|
|||||
|
2020
Q3 | $366K | Buy |
|
|||||
|
2020
Q2 | $271K | Sell |
|
|||||
|
2020
Q1 | $489K | Buy |
|
|||||
|
2019
Q4 | $382K | Buy |
|
|||||
|
2019
Q3 | $318K | Buy |
|
|||||
|
2019
Q2 | $225K | Sell |
|
|||||
|
2019
Q1 | $301K | Buy |
|
|||||
|
2018
Q4 | $182K | Buy |
|
|||||
|
2018
Q3 | $188K | Hold |
|
|||||
|
2018
Q2 | $159K | Hold |
|
|||||
|
2018
Q1 | $150K | Buy |
|
|||||
|
2017
Q4 | $119K | Buy |
|
|||||
|
2017
Q3 | $115K | Buy |
|
|||||
|
2017
Q2 | $107K | Sell |
|
|||||
|
2017
Q1 | $109K | Buy |
|
|||||
|
2016
Q4 | $106K | Sell |
|
|||||
|
2016
Q3 | $138K | Buy |
|
|||||
|
2016
Q2 | $106K | Buy |
|
|||||
|
2016
Q1 | $92K | Hold |
|
|||||
|
2015
Q4 | $81K | Buy |
|
|||||
|
2015
Q3 | $72K | Sell |
|
|||||
|
2015
Q2 | $76K | Buy |
|